Update Jan 12, 2023: I added another reason. SARS-CoV-2 variants of concern developed resistance to interferon as the pandemic progressed. Much new information came out recently about SARS-CoV-2, which causes COVID-19, the antivirals prescribed for it, and its “vaccines.” This article aims to increase awareness that SARS-CoV-2 reinfections can happen no matter if they have…
A new study shows that the emergency-authorized drug for COVID-19, molnupiravir, can induce hundreds of mutations in immune-compromised people.[1] Molnupiravir (Lagevrio) works by causing mutations in the genome of SARS-CoV-2 to produce an ‘error catastrophe’ to stop its replication. A five-day course of 40 capsules taken as four capsules twice daily for five days cost…
An in vitro study from the University of North Carolina at Chapel Hill [1] showed that the new drug developed for COVID-19 could cause mutations in mammalian cells. This raises the possibility that molnupiravir can cause cancer. Molnupiravir is the current drug that Merck is requesting the FDA to have Emergency Use Authorization to treat…
